Literature DB >> 1618053

Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro.

M Hiele1, Y Ghoos, P Rutgeerts, G Vantrappen.   

Abstract

The effect of acarbose on hydrolysis of a pure starch meal was investigated in normal subjects and ileostomy patients by means of 13CO2 breath tests and blood glucose levels as parameters of absorption, and of H2 breath tests, serum acetate levels, and ileal loss of carbohydrate as parameters of malabsorption. Additional information on the effect of acarbose on alpha-amylase activity was obtained by in vitro experiments. Acarbose (200 and 400 mg) significantly delayed starch absorption. Serum acetate was found to be a less sensitive marker of malabsorption than breath H2 excretion. After intake of 50 g starch plus 400 mg acarbose, 23-71% of the starch load was lost in the ileostomy effluent, for a large part as starch. This suggests that acarbose considerably inhibits alpha-amylase, and not only brush-border enzymes. In vitro experiments confirm that an inhibition of two thirds of alpha-amylase activity can be expected from pharmacologically used doses of acarbose.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618053     DOI: 10.1007/bf01300287

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Percolation of starch and soluble carbohydrates from plant tissue for quantitative determination with anthrone.

Authors:  J Hansen; I Moller
Journal:  Anal Biochem       Date:  1975-09       Impact factor: 3.365

2.  Super-efficient starch absorption. A risk factor for colonic neoplasia?

Authors:  J R Thornton; A Dryden; J Kelleher; M S Losowsky
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

3.  Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans.

Authors:  P Layer; A R Zinsmeister; E P DiMagno
Journal:  Gastroenterology       Date:  1986-07       Impact factor: 22.682

4.  Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans.

Authors:  P Layer; G L Carlson; E P DiMagno
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

5.  Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults.

Authors:  G B Haycock; G J Schwartz; D H Wisotsky
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

6.  Effect of acarbose on the 24-hour blood glucose profile and pattern of carbohydrate absorption.

Authors:  R H Taylor; D J Jenkins; H M Barker; H Fielden; D V Goff; J J Misiewicz; D A Lee; H B Allen; G MacDonald; H Wallrabe
Journal:  Diabetes Care       Date:  1982 Mar-Apr       Impact factor: 19.112

7.  Absorption of starch by healthy ileostomates: effect of transit time and of carbohydrate load.

Authors:  R W Chapman; J K Sillery; M M Graham; D R Saunders
Journal:  Am J Clin Nutr       Date:  1985-06       Impact factor: 7.045

8.  Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study.

Authors:  H Ruppin; J Hagel; W Feuerbach; H Schutt; J Pichl; I Hillebrand; S Bloom; W Domschke
Journal:  Gastroenterology       Date:  1988-07       Impact factor: 22.682

Review 9.  Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  S P Clissold; C Edwards
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

10.  A study of 'starch blockers' in man using 13C-enriched starch as a tracer.

Authors:  J S Garrow; P F Scott; S Heels; K S Nair; D Halliday
Journal:  Hum Nutr Clin Nutr       Date:  1983-07
View more
  3 in total

Review 1.  A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.

Authors:  F Santeusanio; P Compagnucci
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

2.  Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial.

Authors:  Xiuying Zhang; Zhiwei Fang; Chunfang Zhang; Huihua Xia; Zhuye Jie; Xueyao Han; Yingli Chen; Linong Ji
Journal:  Diabetes Ther       Date:  2017-01-27       Impact factor: 2.945

3.  Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice.

Authors:  Byron J Smith; Richard A Miller; Aaron C Ericsson; David C Harrison; Randy Strong; Thomas M Schmidt
Journal:  BMC Microbiol       Date:  2019-06-13       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.